CO7091180A2 - Preparación sólida oral de liberación sostenida - Google Patents

Preparación sólida oral de liberación sostenida

Info

Publication number
CO7091180A2
CO7091180A2 CO14220343A CO14220343A CO7091180A2 CO 7091180 A2 CO7091180 A2 CO 7091180A2 CO 14220343 A CO14220343 A CO 14220343A CO 14220343 A CO14220343 A CO 14220343A CO 7091180 A2 CO7091180 A2 CO 7091180A2
Authority
CO
Colombia
Prior art keywords
sustained release
solid oral
release preparation
oral sustained
preparation
Prior art date
Application number
CO14220343A
Other languages
English (en)
Inventor
Robert A Forbes
Suresh Mallikaarjun
Arash Raoufinia
Ron Casey
Junichi Jinno
Hiroyuki Nagao
Donald Diehl
Erik Pecorelli
Anthony Carpanzano
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of CO7091180A2 publication Critical patent/CO7091180A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Se adjunta en pestaña anexos.
CO14220343A 2012-03-06 2014-10-06 Preparación sólida oral de liberación sostenida CO7091180A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261607291P 2012-03-06 2012-03-06

Publications (1)

Publication Number Publication Date
CO7091180A2 true CO7091180A2 (es) 2014-10-21

Family

ID=48014240

Family Applications (1)

Application Number Title Priority Date Filing Date
CO14220343A CO7091180A2 (es) 2012-03-06 2014-10-06 Preparación sólida oral de liberación sostenida

Country Status (17)

Country Link
US (1) US20150037424A1 (es)
EP (1) EP2822989A1 (es)
JP (1) JP2015509482A (es)
KR (1) KR20140131987A (es)
CN (1) CN104159949A (es)
AR (1) AR090245A1 (es)
AU (1) AU2013228315A1 (es)
CA (1) CA2865882A1 (es)
CO (1) CO7091180A2 (es)
EA (1) EA201491640A1 (es)
HK (1) HK1200738A1 (es)
IN (1) IN2014DN06939A (es)
MX (1) MX2014010574A (es)
PH (1) PH12014501853A1 (es)
SG (1) SG11201404915SA (es)
TW (1) TW201343201A (es)
WO (1) WO2013133448A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20200109A1 (ar) 2012-04-23 2017-06-16 Otsuka Pharma Co Ltd مستحضر قابل للحقن
JP2018174986A (ja) * 2017-04-03 2018-11-15 花王株式会社 吸収構造体及びそれを備えた吸収性物品

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006528A (en) 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
AR032641A1 (es) 2001-01-29 2003-11-19 Otsuka Pharma Co Ltd Agonista de subtipo de receptor 5-ht 1a.
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
JP4170032B2 (ja) 2002-07-12 2008-10-22 本多通信工業株式会社 光分岐器及びｏ／ｅ変換コネクタ
US20060193912A1 (en) * 2005-02-28 2006-08-31 Penwest Pharmaceuticals Co. Controlled release O-desmethylvenlafaxine formulations
CN101578096A (zh) 2006-10-10 2009-11-11 潘威斯脱药物公司 稳健的缓释制剂
JP2011513301A (ja) * 2008-02-28 2011-04-28 バイアル−ポルテラ アンド シーエー，エス．エー． 難溶性薬剤のための医薬組成物
WO2010079506A2 (en) * 2008-06-23 2010-07-15 Torrent Pharmaceuticals Ltd. Pharmaceutical composition of aripiprazole
US20120214820A1 (en) * 2009-09-15 2012-08-23 Ratiopharm Gmbh Orally disintegrating pharmaceutical dosage form containing aripiprazole

Also Published As

Publication number Publication date
AR090245A1 (es) 2014-10-29
KR20140131987A (ko) 2014-11-14
WO2013133448A1 (en) 2013-09-12
SG11201404915SA (en) 2014-10-30
MX2014010574A (es) 2014-12-08
CA2865882A1 (en) 2013-09-12
HK1200738A1 (en) 2015-08-14
TW201343201A (zh) 2013-11-01
US20150037424A1 (en) 2015-02-05
EA201491640A1 (ru) 2015-01-30
EP2822989A1 (en) 2015-01-14
AU2013228315A1 (en) 2014-09-04
PH12014501853A1 (en) 2014-11-17
CN104159949A (zh) 2014-11-19
IN2014DN06939A (es) 2015-04-10
JP2015509482A (ja) 2015-03-30

Similar Documents

Publication Publication Date Title
CO7151521A2 (es) Anticuerpos anti-fcrn
BR112012030950A2 (pt) formulações de vacina
DK2787975T3 (da) Robuste formuleringer med kontrolleret frigivelse
CR20130327A (es) Comprimido de desintegración oral
BR112014006689A2 (pt) composição de cuidado oral
BR112012030939A2 (pt) acessório dentário
BR302013001262S1 (pt) Configuração aplicada a um implemento de higiene oral
CO6801778A2 (es) Composiciones de cuidado oral
BR112012022411A2 (pt) articulador
CO7111295A2 (es) Anticuerpo anti-rob04
UY34286A (es) Diagnóstico de vacuna mejorado
FR2995524B1 (fr) Prothese endo-urinaire
FR2972625B1 (fr) Implant dentaire
CO6801767A2 (es) Formulaciones de liberación sostenida de paracetamol
CO6960544A2 (es) Preparación de liberación sostenida
SMT201600367B (it) Indumento intimo
CO7091180A2 (es) Preparación sólida oral de liberación sostenida
CO7151505A2 (es) Formulación oral
ES1076359Y (es) Implante dental
ES2458065B1 (es) Implante dental autofresante
UY33996A (es) Preparacion sólida
DE102012022654A8 (de) Dentales Implantat
ES2464418B1 (es) Prótesis ortodóntica
ES1076119Y (es) Kit de higiene dental
FR2967069B3 (fr) Formulations